These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23124537)

  • 21. An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
    Surendran S; Gundappa C; Gandhi A; Kurien AA; Fernando E
    Saudi J Kidney Dis Transpl; 2017; 28(3):639-644. PubMed ID: 28540906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rituximab for treatment of severe renal disease in ANCA associated vasculitis.
    Geetha D; Hruskova Z; Segelmark M; Hogan J; Morgan MD; Cavero T; Eriksson P; Seo P; Manno RL; Dale J; Harper L; Tesar V; Jayne DR
    J Nephrol; 2016 Apr; 29(2):195-201. PubMed ID: 25986390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
    Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
    J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful therapeutic use of rituximab in refractory Wegener's granulomatosis after renal transplantation.
    Hermle T; Goestemeyer AK; Sweny P; Burns A
    Clin Nephrol; 2007 Nov; 68(5):322-6. PubMed ID: 18044265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The presentation and management of granulomatosis with polyangiitis (Wegener's Granulomatosis) in the pediatric airway.
    Lee PY; Adil EA; Irace AL; Neff L; Son MB; Lee EY; Perez-Atayde A; Rahbar R
    Laryngoscope; 2017 Jan; 127(1):233-240. PubMed ID: 27113905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two cases of refractory Wegener's granulomatosis successfully treated with rituximab.
    Tamura N; Matsudaira R; Hirashima M; Ikeda M; Tajima M; Nawata M; Morimoto S; Kaneda K; Kobayashi S; Hashimoto H; Takasaki Y
    Intern Med; 2007; 46(7):409-14. PubMed ID: 17409608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Evolving Concepts in Treatment.
    Lynch JP; Derhovanessian A; Tazelaar H; Belperio JA
    Semin Respir Crit Care Med; 2018 Aug; 39(4):434-458. PubMed ID: 30404111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis.
    Langford CA
    Clin Exp Immunol; 2011 May; 164 Suppl 1(Suppl 1):31-4. PubMed ID: 21447129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful remission induction with a combination therapy of rituximab, cyclophosphamide, and steroids in a patient with refractory optic neuritis in Wegener's granulomatosis.
    Huchzermeyer C; Mardin C; Holbach L; Zwerina J; Schett G; Rech J
    Clin Rheumatol; 2013 Mar; 32 Suppl 1():S97-101. PubMed ID: 20862503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gingival granulomatosis with polyangiitis (Wegener's granulomatosis) as a primary manifestation of the disease.
    Fonseca FP; Benites BM; Ferrari A; Sachetto Z; de Campos GV; de Almeida OP; Fregnani ER
    Aust Dent J; 2017 Mar; 62(1):102-106. PubMed ID: 27439744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adolescent with severe granulomatosis with polyangiitis: a case report.
    Arfaoui H; Elkihal H; Jabri H; Elkhattabi W; Afif H
    Pan Afr Med J; 2021; 38():285. PubMed ID: 34122712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rituximab for severe refractory pediatric Wegener granulomatosis.
    Patel AM; Lehman TJ
    J Clin Rheumatol; 2008 Oct; 14(5):278-80. PubMed ID: 18824926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab therapy for Wegener's granulomatosis refractory to conventional treatment.
    Sánchez-Escuredo A; Núñez R; Ibernón M; Martínez E; López D; Navarro M; Bonet J; Ara J; Romero R
    Nefrologia; 2011; 31(4):502-4. PubMed ID: 21738261
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful treatment of hypertrophic pachymeningitis in refractory Wegener's granulomatosis with rituximab.
    Sharma A; Kumar S; Wanchu A; Lal V; Singh R; Gupta V; Singh S; Gupta A
    Clin Rheumatol; 2010 Jan; 29(1):107-10. PubMed ID: 19802640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of Wegener's granulomatosis responses to rituximab: current evidence and therapeutic prospects.
    Aouba A; Pagnoux C; Bienvenu B; Mahr A; Guillevin L
    Clin Rev Allergy Immunol; 2008 Feb; 34(1):65-73. PubMed ID: 18270860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Widespread cranial nerve palsies while on cyclophosphamide therapy: a very rare manifestation of Wegener's granulomatosis (granulomatosis with polyangitis).
    Ahmed SV; Chandra S
    BMJ Case Rep; 2013 Oct; 2013():. PubMed ID: 24142466
    [No Abstract]   [Full Text] [Related]  

  • 37. Refractory pituitary granulomatosis with polyangiitis (Wegener's) treated with rituximab.
    Hughes J; Barkhoudarian G; Ciarlini P; Laws ER; Mody E; Inzucchi SE; Woodmansee WW
    Endocr Pract; 2013; 19(1):e1-7. PubMed ID: 23186961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.
    Geetha D; Specks U; Stone JH; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Fessler BJ; Ding L; Tchao NK; Ikle D; Jepson B; Brunetta P; Fervenza FC;
    J Am Soc Nephrol; 2015 Apr; 26(4):976-85. PubMed ID: 25381429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refractory Wegener's granulomatosis responds to tumor necrosis factor blockade.
    Kleinert J; Lorenz M; Köstler W; Hörl W; Sunder-Plassmann G; Soleiman A
    Wien Klin Wochenschr; 2004 May; 116(9-10):334-8. PubMed ID: 15237661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infliximab or rituximab for refractory Wegener's granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients.
    de Menthon M; Cohen P; Pagnoux C; Buchler M; Sibilia J; Détrée F; Gayraud M; Khellaf M; Penalba C; Legallicier B; Mouthon L; Guillevin L
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S63-71. PubMed ID: 21586199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.